PROGRAM CHAIR
Alexa Fiffick, DO, MBS, MSCP
Associate Director of Education, Ms. Medicine
CEO/Founder Concierge Medicine of Westlake
Menopause Expert, Menopause Mandate
Westlake, Ohio
PROGRAM OVERVIEW
This educational activity will target healthcare providers who care for women transitioning through menopause, including those experiencing vasomotor symptoms (VMS) related to cancer endocrine therapy. The program is designed to strengthen clinicians’ understanding of the neurokinin (NK) pathway and its role in linking VMS with sleep disturbances, while reviewing the clinical evidence for emerging nonhormonal therapies, including NK receptor antagonists, across diverse patient populations. It shares patient perspectives and emphasizes the importance of shared decision-making and evidence-based communication strategies to address risk considerations and individualized treatment planning to support optimal management of menopausal VMS.
TARGET AUDIENCE
The educational initiative is designed to meet the needs of healthcare professionals, including OB/GYNs; advanced practice providers specializing in women’s health (NPs, PAs, APRNs, CNMs, and RNs); primary care physicians (family medicine and internal medicine); pharmacists; and medical oncologists.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Identify mechanisms of neurokinin pathway to link VMS with sleep disturbances and when to consider non-hormonal therapies for women transitioning through menopause.
- Integrate clinical evidence for emerging non-hormonal therapies targeting the neurokinin pathway for the treatment of VMS in women, including oncology patients experiencing VMS related to endocrine therapy
- Utilize evidence-based communication strategies that support shared decision-making and improve patient understanding of therapeutic options, risk considerations, and their role in managing VMS due to menopause.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 0.5 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Manufacturer |
| Alexa Fiffick, DO, MBS, MSCP | Dr. Fiffick discloses receiving consulting fees from Bayer HealthCare Pharmaceuticals Inc. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Andrew Grzybowski, CEO of Med Learning Group, has nothing to disclose.
- Lauren Welch, COO of Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator, has nothing to disclose.
- A medical reviewer from CE Peer Review LLC, has nothing to disclose.
- Brianna Hefele, PA-C, has nothing to disclose.
- Sharon Windsor Harker, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Bartunek, Senior Program Manager for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: August 28, 2026
EXPIRATION DATE: August 28, 2027
Copyright © 2026 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
